Company
SOLENO THERAPEUTICS INC (SLNO)
Standardized SEC financial data for SOLENO THERAPEUTICS INC — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001484565 · NASDAQ · Pharmaceutical Preparations.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | $190.4M |
| Cost of revenue | — | — | — | — | — | $2.7M |
| Gross profit | — | — | — |
Standardized from SOLENO THERAPEUTICS INC's SEC filings — per-share figures split-adjusted. Full history via the API.
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $49.2M | $21.3M | $14.6M | $169.7M | $87.9M | $70.1M |
| Inventory |
Get SLNO data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/SLNO/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/SLNO/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"